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Peroxisomes play a central role in lipid metabolism,
and their function depends on molecular oxygen.
Low oxygen tension or von Hippel-Lindau (Vhl) tumor
suppressor loss is known to stabilize hypoxia-induc-
ible factors alpha (Hif-1a and Hif-2a) to mediate
adaptive responses, but it remains unknown if perox-
isome homeostasis and metabolism are intercon-
nectedwith Hif-a signaling. By studying liver-specific
Vhl, Vhl/Hif1a, and Vhl/Hif2a knockout mice, we
demonstrate a regulatory function of Hif-2a signaling
on peroxisomes. Hif-2a activation augments peroxi-
some turnover by selective autophagy (pexophagy)
and thereby changes lipid composition reminiscent
of peroxisomal disorders. The autophagy receptor
Nbr1 localizes to peroxisomes and is likewise deg-
raded by Hif-2a-mediated pexophagy. Furthermore,
we demonstrate that peroxisome abundance is
reduced in VHL-deficient human clear cell renal cell
carcinomas with high HIF-2a levels. These results
establish Hif-2a as a negative regulator of peroxi-
some abundance and metabolism and suggest a
mechanism by which cells attune peroxisomal func-
tion with oxygen availability.
INTRODUCTION
Oxygen (O2) is an essential substrate in cellular metabolism and
signaling and, as such, is inseparably linked to survival and
normal function of all metazoan. Central to the molecular mech-
anisms underlying O2 homeostasis are hypoxia-inducible factors
(HIFs) that function asmaster regulators of the adaptive response
to hypoxia. HIFs are heterodimers composed of a constitutively882 Cell Metabolism 22, 882–897, November 4, 2014 ª2014 Elsevierexpressed HIF-1b subunit and O2-regulated a subunits (HIF-1a
and HIF-2a) (Keith et al., 2012). Under normoxia, HIF-a subunits
are hydroxylated and targeted for proteasomal degradation by
an ubiquitin ligase complex containing the von Hippel-Lindau
(VHL) tumor suppressor protein pVHL. Under hypoxia, HIF-a
hydroxylation is inhibited, thereby stabilizing HIF-a protein.
HIF-a dimerizes with HIF-1b to activate target genes. HIF-1a
and HIF-2a have both common and distinct target genes and
are differentially regulated in various physiological and patho-
physiological conditions, such as cancer and ischemic diseases
(Semenza, 2012; Keith et al., 2012). HIF-induced genes promote
angiogenesis, erythropoiesis, metastasis, and metabolic reprog-
ramming, such as shifting metabolism from oxidative phos-
phorylation to glycolysis. Activation of HIFs also reprograms lipid
metabolism leading to lipid accumulation (Kucejova et al., 2011;
Qu et al., 2011; Kim et al., 2006; Rankin et al., 2009; Krishnan
et al., 2009), but it remains controversial how they promote lipid
accumulation.
Abundant evidence suggests key roles for HIF-1a in the regu-
lation of mitochondrial metabolism (Semenza, 2011). However,
so far there is no evidence linking HIF signaling to peroxisomes,
whose function depends highly on molecular O2. In fact, perox-
isomes may be responsible for as much as 20% of O2 consump-
tion and 35% of H2O2 production in tissues such as the liver
(Fransen et al., 2012). Peroxisomes are extremely versatile and
dynamic organelles whose number, size, and function are
dependent on cell type andmetabolic needs. They play key roles
in the degradation of fatty acids (i.e., very long-chain fatty acids
[VLCFAs] and polyunsaturated fatty acids [PUFAs]), ether lipid
synthesis, cholesterol and bile acid synthesis, and metabolism
of reactive oxygen species (Van Veldhoven, 2010; Faust and Ko-
vacs, 2014; Fransen et al., 2012). The importance of peroxisomal
metabolism is illustrated by peroxisome biogenesis disorders in
which functional peroxisomes are absent or disorders caused by
single peroxisomal enzyme deficiencies (Raymond et al., 2009).
Lack of peroxisomal metabolism leads to extensive cellular
metabolic disarray, and patients with peroxisomal disorders,Inc.
(legend on next page)
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dysfunction with fatty liver, cholestasis, and eventually cirrhosis
(Raymond et al., 2009; Baes and Van Veldhoven, 2012; Faust
and Kovacs, 2014).
Since peroxisomal function depends on O2, we hypothesized
that to minimize O2 consumption under hypoxic conditions,
HIF-a signaling may inhibit O2-dependent peroxisomal meta-
bolism and/or decrease the number of peroxisomes. In addition,
HIF-mediated reduction in peroxisomal activity could promote
metabolic reprogramming causing changes in lipid metabolism.
To test this hypothesis, we chose the mouse liver as model sys-
tem because peroxisomes are highly abundant in the liver, and
liver-specific loss of pVhl causes severe lipid accumulation. In
this study, we systematically investigated peroxisome homeo-
stasis and metabolism in wild-type and liver-specific Vhl, Vhl/
Hif1a, and Vhl/Hif2a knockout mice and explored the role of
Hif-1a and Hif-2a in this context.
RESULTS
Peroxisome Abundance Is Reduced in Vhl–/– Livers
To investigate whether peroxisomal abundance and/or meta-
bolism are regulated by Hif-a, we inactivated the Vhl gene in
the liver. As previously reported (Kucejova et al., 2011; Rankin
et al., 2009), 4-week-old (P28) liver-specific Vhl/ mice were
significantly smaller than control mice but had an increased liver
to bodyweight ratio, displayed severe steatosis, were hypo-
glycemic, and Hif target gene expression was increased (Fig-
ures S1A–S1G available online). Intriguingly, the protein levels
of the peroxisomal matrix proteins catalase, acyl-CoA oxidase
(Acox1), multifunctional protein 1 (Mfp1), urate oxidase (Uox),
as well as the peroxisomal membrane proteins Pex14p and
Pex3p were significantly decreased in livers of P28 Vhl/ mice
(Figure 1A), a phenomenon already evident at 2 weeks of age
(Figure S1H). The effects of pVhl loss on peroxisomal protein
levels were highly selective, as representative ER and mitochon-
drial protein levels were similar in control and Vhl/ mice (Fig-
ures 1A and S1H). Only the mitochondrial outer membrane
protein Vdac was moderately reduced in P28 Vhl/ mice. Anal-
ysis of the number of peroxisomes by cytochemical localization
of catalase and immunofluorescence of Pex14p and Acox1
revealed a strong reduction in peroxisome abundance in P14–
P28 Vhl/ livers (Figures 1B and S1I). Catalase activity was
decreased 60%–70% in Vhl/ livers compared with control
livers (Figures 1C and S1J). Electron microscopic comparisons
of control and Vhl/ livers revealed that peroxisomes are similar
in size and shape (Figure S1K).Figure 1. Peroxisome Abundance Is Decreased in Vhl–/– Livers
Peroxisomes were analyzed in P28 Vhlf/f (control) and liver-specific Vhl/ mice.
(A) Immunoblots of liver lysates with antibodies against peroxisomal matrix (Ca
mitochondrial (Vdac), and ER (ERp57 and Grp94) proteins.
(B) Cytochemical localization of catalase and immunofluorescence of Pex14p an
(C) Catalase activity in liver lysates.
(D) Concentration spectrum of TAG species. TAGs are designated numerically as
for detailed quantitative lipid profiles.)
(E) Relative abundance of the TAG lipid species in Vhl/ livers normalized to co
(F) Fatty acid profiles in total lipid extracts from livers were determined by gas c
normalized to an internal standard and expressed as percentage of total fatty acid
mice.
884 Cell Metabolism 22, 882–897, November 4, 2014 ª2014 ElsevierTo characterize the peroxisomal population in more detail, we
isolated peroxisomes from control and Vhl/ livers (Figure S2A).
Catalase activity was significantly decreased in postnuclear su-
pernatants from Vhl/ livers (Figure S2B). Peroxisomal protein
levels were significantly decreased in subcellular fractions from
Vhl/ livers, whereas levels of the mitochondrial proteins
Tomm20, Trap1, and Vdac were similar to controls (Figure S2C).
Immunoblots of gradient fractions from control livers showed
that peroxisomes were enriched in fractions 17–20 (density
range of 1.144–1.169 g/ml), whereas peroxisomal protein levels
were significantly decreased in gradient fractions from Vhl/
livers (Figure S2D). The distribution pattern of catalase activity
displayed a major peak coincident with peroxisomal proteins in
control livers, and catalase activity was significantly decreased
in Vhl/ livers (Figure S2E). These results argue for the presence
of intact peroxisomes in Vhl/ livers, but the distribution pattern
of peroxisomal proteins suggests a heterogeneous peroxisome
population. In summary, hepatic loss of Vhl function is associ-
ated with a reduction in peroxisome abundance.
Changes in Lipid Composition in Vhl–/– Livers Are
Reminiscent of Peroxisomal Disorders
Since peroxisomes play important roles in the degradation of
VLCFAs and VLC-PUFAs, as well as in the synthesis of polyun-
saturated FAs, we investigated whether the decrease in peroxi-
some abundance had consequences on the lipid composition in
Vhl/ livers. We quantified the major lipid classes and the distri-
bution of fatty acids within these classes in P28 control and
Vhl/ livers and observed profound lipid alterations in Vhl/
livers. The profile of triacylglycerol (TAG) species showed a
disproportionate increase of TAGswith VLCFAs and VLC-PUFAs
in Vhl/ livers (Figures 1D and 1E; Table S1). C62 to C64 species
were hardly detectable in control livers but reached concentra-
tions between 10–100 nmol/g liver tissue in Vhl/ livers. Most
TAG species showed an accumulation of 10-fold in Vhl/
livers, but TAG species with a higher number of double bonds
were disproportionately increased 30- to 100-fold (Figures 1D
and 1E). Next, we determined the distribution of fatty acids in
the liver. The hepatic levels of docosahexaenoic (DHA, C22:6n3)
and arachidonic acid (AA, C20:4n6) were significantly decreased
in Vhl/ mice, whereas the parent fatty acids, linolenic
(C18:3n3) and linoleic acid (C18:2n6), respectively, as well as doco-
sapentaenoic acid (C22:5n3) upstream to DHA synthesis were
significantly increased (Figure 1F; Table S2). Blood levels of
VLCFA C26:0 and C24:0 lyso-phosphatidyl cholines were
increased in Vhl/ mice (Figure S1L). Hence, VLCFAs and
VLC-PUFAs accumulations as well as DHA and AA deficienciestalase, Acox1, Mfp1, and Uox) and membrane proteins (Pex14p and Pex3p),
d Acox1 in livers.
carbon and double bond number (after the colon) in acyl chains. (See Table S1
ntrol values.
hromatography-mass spectrometry (GC-MS). Relative signal intensities were
s. Data are mean ± SD (n = 6). *p < 0.05; **p < 0.01; ***p < 0.001 versus control
Inc.
Figure 2. Hif-2a-Dependent Decrease of Peroxisome Abundance in Vhl–/– Livers
Peroxisomes were analyzed in P28 control (Cre: Vhlf/f, Vhlf/f/Hif1af/f, and Vhlf/f/Hif2af/f) and liver-specific Vhl/, Vhl//Hif1a/, and Vhl//Hif2a/ mice.
(A) Immunoblots of peroxisomal proteins, Hif-2a, and pVhl in liver lysates.
(B) Immunofluorescence of Pex14p in livers.
(C) Catalase activity in liver lysates.
(legend continued on next page)
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changes in lipid composition are reminiscent of alterations due to
defective peroxisomal b-oxidation in peroxisome-deficient mice
and patients with peroxisomal disorders (Baes and Van Veld-
hoven, 2012; Raymond et al., 2009; Van Veldhoven, 2010).
Hif-2a but Not Hif-1a Activation Mediates the Decrease
of Peroxisome Abundance in Vhl–/– Livers
To examine if the reduction of peroxisome number upon pVhl
loss is mediated by Hif-1a or Hif-2a, we analyzed peroxisome
abundance in liver-specific Vhl/Hif1a and Vhl/Hif2a double
knockout mice (Figures 2 and S3). P28–P42 Vhl//Hif1a/
mice were significantly smaller than control mice, they were hy-
poglycemic, and their liver was enlarged and revealed severe
steatosis similar to Vhl/ mice (Figures S3A–S3C). In contrast,
Vhl//Hif2a/ mice were phenotypically similar to control
mice (Figure S3A). With respect to the peroxisomal phenotype,
we observed a striking rescue in Vhl//Hif2a/ but not
Vhl//Hif1a/ mice. Peroxisomal protein levels were signifi-
cantly decreased in Vhl//Hif1a/ livers (Figures 2A and
S3D), whereas their levels were similar in control and Vhl//
Hif2a/ livers (Figures 2A and S3E). Immunofluorescence of
Pex14p revealed a strong reduction of peroxisome number in
Vhl//Hif1a/ but not Vhl//Hif2a/ livers (Figure 2B). Cata-
lase activity was similarly decreased in P28 Vhl/ and Vhl//
Hif1a/ livers compared to controls, whereas catalase activity
was similar in control and Vhl//Hif2a/ livers (Figures 2C
and S3F). Hepatic TAG levels were significantly increased in
Vhl/ and Vhl//Hif1a/ livers and only marginally increased
in Vhl//Hif2a/ livers compared to controls (Figure 2D). The
expression of Hif target genes was, with the exception of Epo,
similarly increased in P28–P42 Vhl/, Vhl//Hif1a/, and
Vhl//Hif2a/ livers (Figures 2E and S3G). Thus, both Hif-1a
and Hif-2a were stabilized in Vhl/ livers, but the reduction in
peroxisome number depends exclusively on Hif-2a activity.
Liver-specific loss of Hif-1a or Hif-2a alone did not affect perox-
isomal protein levels (Figure S3H).
Next, we investigated the composition of hepatic TAGs in
Vhl//Hif1a/ and Vhl//Hif2a/ livers. TAG species with
VLCFAs and VLC-PUFAs increased in Vhl//Hif1a/ livers
(Figure 2F; Table S1) but changed only moderately in Vhl//
Hif2a/ livers (Figure S3I; Table S1). Changes in the fatty acid
profile of Vhl//Hif1a/ livers were similar as in Vhl/ livers
(Figure 2G; Table S2). Importantly, fatty acid profiles from Vhl/
and Vhl//Hif1a/ livers were comparable to P13 peroxisome-
deficientPex2/ livers that also displayed steatosis (Figure S4A)
(Keane et al., 2007; Kovacs et al., 2012).
Bile acids were analyzed in plasma from our mouse models.
The plasma of Vhl/ and Vhl//Hif1a/ mice was yellowish
with increased levels of cholic acid (CA) and chenodeoxycholic
acid (CDCA) (Figures S4B and S4C), which is a sign of chole-
stasis. Importantly, the levels of the C27-bile acids 3a,7a-dihy-(D) Hepatic TAG content.
(E) Expression of Hif target genes in P28 livers. Each value represents the amoun
(F) Concentration spectrum of TAG species in livers. Data are mean ± SD (n = 6;
(G) Fatty acid profiles in total lipid extracts from livers were determined by GC-MS
internal standard and expressed as percentage of total fatty acids. Data are mea
Hif1a/, n = 4 for Vhlf/f/Hif2af/f, n = 5 for Vhl//Hif2a/ mice). *p < 0.05; **p <
886 Cell Metabolism 22, 882–897, November 4, 2014 ª2014 Elsevierdroxycholestanoic acid (DHCA) and 3a,7a,12a-trihydroxycho-
lestanoic acid (THCA) were significantly increased in the
plasma of these mice (Figures S4B and S4C). C27-bile acids
accumulate in plasma of patients and mice with peroxisome
deficiency disorders; they are toxic and have been suggested
to contribute to liver disease associated with peroxisomal disor-
ders (Keane et al., 2007; Ferdinandusse et al., 2009; Hiebler
et al., 2014). CA and CDCA levels were similar in the plasma
of control and Vhl//Hif2a/ mice, and DHCA and THCA
levels were decreased in the plasma of Vhl//Hif2a/ mice
compared to controls (Figure S4D).
Peroxisome Proliferation Can Be Induced in Vhl–/– Livers
Peroxisome homeostasis is achieved by balancing biogenesis
and degradation of peroxisomes. To explore potential mecha-
nisms underlying the pronounced reduction of peroxisome
abundance in Vhl/ livers, we assessed the expression of Pex
genes, which encode peroxins essential for peroxisome biogen-
esis (Smith and Aitchison, 2013). The expression of Pex genes
was similar in P14–P28 control and Vhl/ livers (Figures 3A
and S1M). Pex11a was the only peroxin that showed significant
transcriptional upregulation in Vhl/ (Figures 3A and S1M) and
Vhl//Hif1a/ (Figure 3B) livers, whereas Pex11a was similarly
expressed in control andVhl//Hif2a/ livers (Figure 3B). Since
overexpression of Pex11a promotes peroxisome division and in-
duces peroxisome abundance (Schrader et al., 2012), this result
may reflect a feedback loop in which Vhl/ and Vhl//Hif1a/
hepatocytes sense the reduction of peroxisomes and attempt to
counterbalance their lack by inducing a positive regulator of
peroxisome biogenesis.
Given the fact that the expression of the peroxisome biogen-
esis machinery was not impaired in Vhl/ livers and that perox-
isome biogenesis proceeds, at least in part, through division of
pre-existing peroxisomes, we tested whether pharmacological
induction of peroxisome proliferation was possible in Vhl/
livers.We treated Vhl/mice either withWY-14,643 (WY), which
is a peroxisome proliferator-activated receptor a (Ppara) ligand,
or 4-phenylbutyrate (PBA), which acts independently of Ppara.
Treatment of mice for 3 days with PBA resulted in a strong induc-
tion of catalase activity (Figure 3C) and peroxisomal protein
levels (Figure 3E) in control and Vhl/ livers. However, PBA
treatment was stopped after 3 days due to a negative effect on
the health state of Vhl/mice. WY treatment for 7 days strongly
increased catalase activity (Figure 3D) and peroxisomal protein
levels in control livers and to a lesser extent in Vhl/ livers (Fig-
ure 3F). Cytochemical staining of catalase activity revealed that
peroxisome number was significantly increased both in control
and Vhl/ livers upon WY treatment (Figure 3G), but in Vhl/
livers, peroxisome abundance was still lower than in untreated
controls. Electron microscopy demonstrated that peroxi-
somes from Vhl/ livers were similarly shaped as those from
control mice, although generally smaller in size (Figure 3G).t of mRNA relative to that in control mice, which was arbitrarily defined as 1.
see Table S1 for detailed quantitative lipid profiles).
(n = 6mice for each genotype). Relative signal intensities were normalized to an
n ± SD (n = 7 for Vhlf/f, n = 5 for Vhl/, n = 3 for Vhlf/f/Hif1af/f, n = 4 for Vhl//
0.01; ***p < 0.001 versus control mice.
Inc.
Figure 3. WY and PBA Induce Peroxisome Proliferation in Vhl–/– Mice
(A) Expression of Pex genes in P28 livers (n = 5–7 mice).
(B) Expression of Pex11a in P28–P42 livers (n = 10 mice).
(C and D) Catalase activity in liver lysates.
(legend continued on next page)
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PBA or WY treatment was insufficient to reduce hepatic TAG
levels and rescue the massive steatosis in Vhl/ mice (Figures
3H and 3I). These results argue for a functional peroxisome
biogenesis machinery in Vhl/ livers.
Since peroxisome proliferation in Vhl/mice was onlymoder-
ately increased in response to WY treatment and accumulation
of VLCFAs and VLC-PUFAs is known to induce Ppara signaling
and peroxisome proliferation, we determined the mRNA levels
of Ppara target genes in WY-treated mice (Figure 3J). The
mRNA levels of Ppara and its target genes were significantly
increased both in control and Vhl/ mice upon WY treatment
(Figure 3J), but WY-mediated transcriptional induction of Ppara
target geneswasmuchweaker in Vhl/mice (Figure 3J). Except
for Pex11a, Ppara target gene expression was similar in vehicle-
treated control and Vhl/ mice (Figure 3J). Likewise, induction
of Ppara target genes was impaired upon fasting in Vhl/
mice, whereas their expression was similar in ad-libitum-fed
control and Vhl/ mice (Figure 3K). Thus, Hif-2a signaling has
a repressive effect on ligand-dependent Ppara transcriptional
activity and by extension on stimulated peroxisome biogenesis.
Autophagy Is Induced in Vhl–/– Mice
Since peroxisome biogenesis and proliferation are functional, we
addressed if increased degradation of peroxisomes underlies
the pronounced reduction of peroxisome abundance in Vhl/
livers. Three mechanisms for peroxisome degradation have
been described in mammalian cells, which include selective
autophagy (pexophagy), proteolysis by Lon protease 2
(Lonp2), and 15-lipoxygenase-1 (Alox15)-mediated autolysis
(Till et al., 2012). To quantify autophagic flux in vivo, control
and Vhl/ mice were infected with an adenovirus expressing
GFP-tagged LC3 (Ad-GFP-LC3). The number of GFP-LC3-posi-
tive vesicles was increased 3-fold in Vhl/ livers compared to
control mice (Figure 4A), indicating increased autophagic flux.
Conversion of nonlipidated LC3-I into the phosphatidylethanol-
amine-conjugated LC3-II form was significantly increased and
protein levels of the autophagic substrate p62 were decreased
in Vhl/ livers (Figure 4B). In summary, these results show
that autophagic flux is increased in Vhl/ livers.
Immunofluorescence of catalase revealed that GFP-LC3-pos-
itive autophagosomes colocalized with peroxisomes in Vhl/
livers (Figures 4C, S5A, and S5B). We analyzed the autophagic
sequestration of peroxisomes with superresolution microscopy
capable of 3D-structured illumination (3D-SIM), which provides
an increase of both axial and lateral resolution by a factor of
two compared to confocal microscopy. Reconstructed 3D-SIM
images show that both single andmultiple peroxisomeswere se-
questrated in autophagosomes and surrounded by an autopha-
gosomal membrane decorated with GFP-LC3 (Figures 4D, S5C,
and S5D; Movies S1 and S2). Importantly, autophagosome-like(E and F) Immunoblots of peroxisomal proteins in liver lysates.
(G) Cytochemical localization of catalase in livers. Electron micrographs of ultrat
(H and I) Hepatic TAG content in livers.
(J) Expression of Ppara target genes in livers.
(K) Expression of Ppara target genes in livers from ad-libitum-fed and overnight-fa
mice: n = 3) (Vehicle: n = 4–8 mice; WY: n = 4–8mice) (Vehicle: n = 3 mice; PBA: n =
fed control mice. #, p < 0.05; ##, p < 0.01; ###, p < 0.001 versus WY- or PBA-tre
888 Cell Metabolism 22, 882–897, November 4, 2014 ª2014 Elsevierstructures containing either single or clusters of peroxisomes
were detected by electron microscopy in hepatocytes of Vhl/
but not in control mice (Figures 4E and 4F), arguing for increased
pexophagy in Vhl/ livers.
Lonp2 expression was similar in control and Vhl/, Vhl//
Hif1a/, and Vhl//Hif2a/ livers (Figures S5F–S5H). Hepatic
mRNA levels of Alox15 were very low and only moderately
increased in Vhl/ and Vhl//Hif1a/ livers compared to con-
trols (Figures S5F and S5G). Protein levels of Alox15 were similar
in control and Vhl/ livers (Figure S5E). Hence, Lonp2 and
Alox15 do not behave as Hif target genes whose induction could
promote peroxisome turnover.
The Autophagy Machinery Is Required for
Hif-2a-Mediated Pexophagy
To directly assess whether autophagy is responsible for the
peroxisomal phenotype in Vhl/ livers, we examined the effect
of constitutive Hif-2a signaling on peroxisome abundance in
liver-specific, autophagy-deficient Atg7/ mice. We generated
an adenovirus coexpressing GFP and HIF-2a P405/531A (here-
after called Ad-HIF-2a(mt)), a HIF-2a variant that escapes degra-
dation by pVHL. We injected Atg7f/f and liver-specific Atg7/
mice either with Ad-HIF-2a(mt) or an adenovirus expressing
GFP (Ad-GFP) as control and sacrificed mice after 6 days.
Expression of HIF-2a(mt) caused hepatomegaly and severe stea-
tosis in Atg7f/f livers, while Atg7/ livers remained unaffected
(Figure 5A). Almost all hepatocytes in Atg7f/f livers expressing
HIF-2a(mt) displayed macrovesicular steatosis (Figure 5A), an ef-
fect not seen in HIF-2a(mt)-expressing Atg7/ livers (Figure 5A).
Peroxisome abundance and peroxisomal protein levels were
significantly decreased in Atg7f/f livers expressing HIF-2a(mt)
compared to controls (Figures 5B and 5C), while peroxisome
homeostasis was similar in Atg7/ hepatocytes expressing
HIF-2a(mt) compared to GFP-expressing Atg7/ hepatocytes.
Overexpression of HIF-2a(mt) did not affect mitochondrial and
ER protein levels (Figure 5C). In accord with the histological anal-
ysis revealing severe steatosis, lipid droplet protein Adfp (adipose
differentiation-related protein) levels increased significantly in
Atg7f/f but not Atg7/ livers expressing HIF-2a(mt) (Figure 5C).
Catalase activity was decreased 60% in Atg7f/f and remained
unchanged in Atg7/ livers expressing HIF-2a(mt) as compared
to controls (Figure 5D).
Although Atg7f/f and Atg7/mice received identical amounts
of Ad-HIF-2a(mt), HIF-2a(mt) protein levels were higher in Atg7f/f
compared to Atg7/ livers (Figure 5C). A possible explanation is
that autophagy is important for efficient adenoviral infection and
replication (Zeng and Carlin, 2013). Hence, one could argue that
the amounts of HIF-2a(mt) produced in Atg7/ liver cells are
insufficient to promote pexophagy. To address this, we
compared Hif-2a levels in Vhl/ and Vhl//Hif1a/ livers
with HIF-2a(mt) levels in Atg7/ livers (Figure 5E). Hif-2a levelshin sections are shown in the right panel.
sted P28 mice. Data are mean ± SD (Ad-libitum-fed mice: n = 5–7; 12 hr fasted
5mice). *p < 0.05; **p < 0.01; ***p < 0.001 versus vehicle-treated or ad libitum-
ated or fasted control mice.
Inc.
Figure 4. Autophagic Flux Is Increased in Vhl–/– Livers
Control and Vhl/ mice were infected with Ad-GFP-LC3, treated with CQ, and sacrificed at the age of 4 weeks.
(A) Representative pictures of GFP-LC3 punctate structures in hepatocytes and quantification of GFP-LC3 punctate structures per cell. Data are mean ± SD.
**p < 0.01.
(B) Immunoblots of autophagy-related proteins in liver lysates.
(C) Immunofluorescence analysis for the colocalization of autophagosomes with peroxisomes. Liver sections were immunostained for GFP and catalase.
Arrowheads: yellow dots represent colocalized GFP-LC3-positive autophagosomes with red fluorescence-labeled peroxisomes. See also Figures S5A and S5B
for analysis of confocal z stack images with the orthogonal slicer tool of the Imaris software.
(legend continued on next page)
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in Atg7/ livers. Since Vhl//Hif1a/ livers revealed a strong
reduction in peroxisome abundance, HIF-2a(mt) levels in
Atg7/ livers are likely sufficient to induce Hif-2a-mediated pex-
ophagy, and the deficiency of autophagy prevents this outcome.
To further corroborate this assertion, we asked whether lowering
HIF-2a(mt) levels in Atg7f/f mice by injection of less pfus could
still decrease peroxisome abundance. Injection of different
pfus resulted in a dose-dependent decrease of HIF-2a(mt) levels
(Figure 5F) and a mosaic infection pattern in those livers (Fig-
ure S6A). A direct comparison of peroxisome abundance in in-
fected and uninfected hepatocytes revealed a strong reduction
in peroxisome numbers in hepatocytes expressing HIF-2a(mt)
compared to uninfected hepatocytes (Figures 5G and S6B).
We determined the expression of Hif target genes in Atg7f/f
and Atg7/ mice infected with different amounts of Ad-HIF-
2a(mt). The mRNA levels of Hif target genes were significantly
increased in livers of Atg7f/f and Atg7/ mice infected with
33 109 pfu of Ad-HIF-2a(mt) compared to controls (Figure S6C),
but the induction was much weaker in Atg7/ livers. However,
their expression was comparable to Atg7f/f mice infected with
1 3 109 pfu of Ad-HIF-2a(mt) (Figure S6C). In mice infected
with low doses of Ad-HIF-2a(mt) (1 3 108 or 5 3 108 pfus), little,
if any, induction of Hif target genes was observed. These results
suggest that Atg7/ livers display a mosaic infection pattern
and that infected hepatocytes produce sufficient HIF-2a(mt) to
induce pexophagy.
Overexpression of HIF-2a(mt) in Atg7f/f mice led to similar
changes in hepatic lipid composition as seen in Vhl/ and
Vhl//Hif1a/ livers. Most TAG species showed an accumula-
tion of10-fold in HIF-2a(mt)-expressingAtg7f/f livers compared
to controls, and TAGs with VLCFAs and fatty acids with a high
number of double bonds were again disproportionately
increased up to 160-fold (Figures 5H and S6D). In summary,
these results support the view that Hif-2a-mediated pexophagy
requires a functional autophagymachinery, and HIF-2a(mt) gain-
of-function leads to similar lipid changes as Vhl/ and Vhl//
Hif1a/ livers.
Pharmacological Inhibition of Autophagy Increases
Peroxisome Abundance in Vhl–/– Livers
Next, we tested whether pharmacological inhibition of auto-
phagy would restore peroxisome abundance in Vhl/ livers.
Treatment of Vhl/ mice with chloroquine (CQ) significantly
increased peroxisomal protein levels inVhl/ livers (Figure S7A).
To inhibit autophagy early at presequestration steps (Petiot et al.,
2000; Seglen and Gordon, 1982), P21 control and Vhl/ mice
were treated with 3-methyladenine (3-MA) for 5 days. 3-MA-
treated Vhl/ mice displayed improved tonus and activity
compared to untreated Vhl/ mice. Peroxisome abundance(D) Superresolution microscopy shows that both single (left panel) or multiple (righ
surrounded by an autophagosomal membrane decorated with GFP-LC3. Liver sec
S5C and S5D and Movies S1 and S2.
(E and F) Electron microscopy detection of peroxisomal autophagy in Vhl/ live
electron-dense precipitate over the organelle.
(E) The left panel shows a double-membrane structure, possibly a phagophore, en
within a double-membrane autophagosome.
(F) A cluster of peroxisomes is contained in a single-membrane-bound compartm
890 Cell Metabolism 22, 882–897, November 4, 2014 ª2014 Elsevierwas significantly increased in livers of 3-MA-treated Vhl/
mice (Figures 6A and 6B), while peroxisomal protein levels
were similar in untreated and 3-MA-treated control livers. Resto-
ration of peroxisome abundance in 3-MA-treated Vhl/ mice
confirmed that loss of peroxisomes in Vhl/ livers is due to
enhanced pexophagy, whereas lack of peroxisome accumula-
tion in treated control mice suggests that their turnover rate un-
der basal conditions is low. Hif target gene expression was not
affected by 3-MA treatment (Figure S7E). Adfp protein levels
were decreased in 3-MA-treated Vhl/ mice compared to un-
treated Vhl/ mice (Figure 6A), which is consistent with attenu-
ated hepatic steatosis (Figure S7B). 3-MA treatment did not
affect ER and mitochondrial protein levels (Figure 6A). These
data corroborate the functional requirement for autophagy in
the decrease in peroxisome content downstream of Hif-2a stabi-
lization in Vhl/ livers.
Protein levels of the selective autophagy receptors p62 and
Nbr1 (neighbor of BRCA1 gene 1) (Rogov et al., 2014) were
increased in 3-MA-treated Vhl/ mice compared to untreated
Vhl/ mice (Figure 6A) and were similar in untreated and 3-
MA-treated control mice. Nbr1 and p62 levels and peroxisome
abundance were concomitantly decreased in Vhl//Hif1a/
livers, whereas their levels were similar in control and Vhl//
Hif2a/ livers (Figure 6C). Loss of Atg7 resulted as expected
in the accumulation of Nbr1 and p62, and Nbr1 levels were
decreased in Atg7f/f livers expressing HIF-2a(mt) (Figure 6C).
Overexpression of NBR1 and p62 has been shown to induce
degradation of peroxisomes (Deosaran et al., 2013), but mRNA
levels of Nbr1 and p62 were similar in control and Vhl/,
Vhl//Hif1a/, and Vhl//Hif2a/ livers (Figures S7C and
S7D). In addition, overexpression of HIF-2a in Atg7f/f livers
decreased mRNA levels of Nbr1 and p62 (Figure S6C). These re-
sults demonstrate that Nbr1 and p62 are not Hif target genes
whose induction could promote pexophagy.
Since our data suggested that Nbr1 and p62 are involved in
Hif-2a-mediated pexophagy, we determined the subcellular
localization of Nbr1 and p62. The prediction would be that
Nbr1 and/or p62 localize to peroxisomes in Vhl/ mice to
mediate pexophagy. Immunofluorescence of catalase revealed
colocalization of peroxisomes with Nbr1 and p62 in untreated
Vhl/ mice (Figures 6D and S7F). Interestingly, Nbr1 already
localized to peroxisomes in control livers, whereas p62 was
barely detectable (Figures 6D and S7F). p62 accumulated as
focal aggregates in 3-MA-treated control livers, and some of
these aggregates showed colocalization with Nbr1 and catalase,
but in contrast to Nbr1, most peroxisomes did not colocalize with
p62 (Figure S7F). In addition to the restoration of peroxisome
abundance, we observed significant clustering of Nbr1- and
p62-positive peroxisomes in 3-MA-treated Vhl/ mice (Figures
6D and S7F). Moreover, immunofluorescence revealed thatt panel) peroxisomes (shown in red) are sequestrated in autophagosomes and
tions were stained with antibodies against GFP and catalase. See also Figures
rs. Livers were fixed and stained with DAB for catalase, which generates an
closing a peroxisome. The right panel shows a peroxisome that is sequestered
ent, representing a putative autolysosome.
Inc.
(legend on next page)
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catalase in Vhl/ livers (Figure S7G).
Analysis of purified peroxisomes from livers of untreated and
3-MA-treated control and Vhl/mice also confirmed the perox-
isomal localization of Nbr1 (Figures S2, S7H, and S7I). 3-MA
treatment significantly increased catalase activity in peroxisomal
peak fractions of control and Vhl/ livers (Figure S7H). Interest-
ingly, the density of peroxisomes was increased in 3-MA-treated
mice (Figure S7H). Peroxisomal protein levels were increased in
gradient fractions of 3-MA-treated Vhl/mice compared to un-
treated knockouts (Figure S7I). Nbr1 was present in peroxisomal
fractions from untreated control livers, whereas in untreated
Vhl/ livers Nbr1 was not detected probably due to the low
amount of peroxisomes (Figures S2D and S7I). 3-MA treatment
increased Nbr1 and p62 protein levels and both autophagic re-
ceptors were present in peroxisomal fractions of control and
Vhl/ livers (Figure S7I). Collectively, we conclude that Nbr1
and p62 are recruited to peroxisomes and participate in Hif-
2a-mediated pexophagy in Vhl/ livers, where they are deg-
raded together with peroxisomes in autolysosomes.
Peroxisome Abundance Is Reduced in Clear Cell Renal
Cell Carcinomas with High HIF-2a Levels
To explore the relevance of HIF-2a-dependent pexophagy in
human disease, peroxisome abundance was analyzed in more
than 200 clear cell renal cell carcinoma (ccRCC) tissue samples
on a tissue microarray (TMA) and compared with HIF-2a expres-
sion and differentiation grade. This disease setting was chosen
for several reasons. First, loss of VHL function occurs in up to
90% of sporadic ccRCC, the most common form of kidney can-
cer (Hakimi et al., 2013). Second, HIF-2a is considered to be a
driver oncoprotein for ccRCC. Third, peroxisomes are highly
abundant in the kidney, and kidneys are affected in peroxisome
biogenesis disorder patients. Fourth, at least in the context of
steatosis and angiogenesis, ccRCC and Vhl/ livers behave
similarly.
Peroxisome abundance varies between the different cell types
of the kidney. They are highly abundant in cells of proximal tu-
bules and less abundant in distal tubules and collecting duct
(Figure 7A). Organelle abundance was classified according to
the situation in normal tissue: many organelles correspond to
proximal tubules, a medium number to distal tubules and few or-
ganelles describe a number below the abundance observed in
normal kidney tissue (Figure 7B). In tumor specimen with strong
HIF-2a staining, 42% had few peroxisomes and only 8% had
many peroxisomes (Figure 7D). Among the specimens that
were negative for HIF-2a only 15% displayed few peroxisomesFigure 5. Overexpression of HIF-2a P405/531A (HIF-2a(mt)) Reduces P
(A) Hematoxylin and eosin staining on liver sections.
(B) Immunofluorescence of Pex14p and GFP in livers. Some Atg7/ hepatocyte
reconstruction revealed that these clusters represent a network of interconnecte
and S4).
(C) Immunoblots of liver lysates. The asterisk indicates a nonspecific band.
(D) Catalase activity in liver lysates. Data are mean ± SD (Ad-GFP: n = 3–6; Ad-H
(E and F) Immunoblots of Hif-2a in P28 liver lysates.
(G) Immunofluorescence of Pex14p and GFP in livers from Atg7f/f mouse infecte
(H) Concentration spectrum of TAG species in livers of Atg7f/f mice infected with
detailed quantitative lipid profiles).
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peroxisomes (Figure 7D). Interestingly, peroxisome abundance
is reduced more frequently in well-differentiated grade 1 as in
grade 2 or 3 tumors (Figure 7E). In summary, the negative regu-
latory effect of HIF-2a signaling on peroxisome abundance is not
restricted to hepatocytes and may extend to other tissues and
disease settings that are characterized by high levels of HIF-2a
such as ccRCC.
DISCUSSION
The main finding of this report is that the transcription factor Hif-
2a, but not Hif-1a, is a negative regulator of peroxisome abun-
dance in hepatocytes. In fact, Hif-2a promotes pexophagy since
Hif-2a-mediated downregulation of peroxisome abundance was
suppressed in liver-specific autophagy-deficient Atg7/ mice
and after inhibition of autophagy with 3-MA in Vhl/ mice. The
autophagy receptor Nbr1 localizes to peroxisomes and is
degraded together with peroxisomes by Hif-2a-mediated pex-
ophagy. Reduced number of peroxisomes and the ensuing defi-
ciency in peroxisomal function encompass major changes in the
hepatic lipid profile that are reminiscent of peroxisomal disorders
and include the accumulation of VLCFAs and VLC-PUFAs.
These lipids are activating ligands for the transcription factor
Ppara, a promoter of peroxisome proliferation. However, Hif-
2a restrains ligand-induced Ppara-mediated peroxisome pro-
liferation. Thus, by simultaneously inducing pexophagy and
counteracting Ppara, Hif-2a ensures efficient depletion of the
peroxisome pool (Figure 7F). Finally, we demonstrate that perox-
isome abundance is significantly reduced in ccRCCs that are
characterized by high HIF-2a levels, providing a link between
reduced peroxisome abundance and HIF-2a expression in hu-
man disease.
Peroxisomes adapt rapidly to cellular demands, and their ho-
meostasis is achieved by the counterbalance between organelle
biogenesis and degradation (Smith and Aitchison, 2013; Till
et al., 2012). Peroxisomal function depends highly on molecular
O2, and the identification of Hif-2a as an activator of pexophagy
suggests that peroxisome homeostasis is directly coupled to O2
availability. Hence, Hif-2a-mediated pexophagymaywell be part
of adaptive responses to hypoxia. Hypoxia signaling is involved
in the pathogenesis of various liver diseases that are associated
with changes in lipid metabolism (Nath and Szabo, 2012), and
Hif-2a-mediated pexophagy might contribute to those changes
in lipid metabolism. Indeed, we showed that Hif-2a-mediated
pexophagy associated with decreased peroxisomal metabolism
resulted in the accumulation of VLCFAs and VLC-PUFAs anderoxisome Abundance in Atg7f/f but Not in Atg7–/– Livers
s displayed large peroxisomal clusters, and confocal z stack analysis with 3D
d, reticular peroxisomal structures and individual peroxisomes (see Movies S3
IF-2a(mt): n = 7). ***p < 0.001 versus GFP-infected mice.
d with 1 3 109 pfu of Ad-HIF-2a(mt).
Ad-GFP or Ad-HIF-2a(mt). Data are mean ± SD (n = 6 to 7) (see Table S1 for
Inc.
Figure 6. Inhibition of Autophagy with 3-MA Increases Peroxisome Abundance in Vhl–/– Livers
(A) Immunoblots of liver lysates.
(B) Immunofluorescence of Pex14p in livers.
(legend continued on next page)
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Hif-2a Promotes Mammalian Pexophagydepletion of DHA and AA. Such lipid changes are characteristic
features of peroxisomal disorders (Van Veldhoven, 2010; Ray-
mond et al., 2009; Baes and Van Veldhoven, 2012). Decreased
DHA and AA levels have also been observed in patients with
nonalcoholic fatty liver disease and steatohepatitis (Puri et al.,
2007, 2009). Since substrates for peroxisomal b-oxidation also
include branched-chain and dicarboxylic FAs, C27-bile acids,
and eicosanoids (Van Veldhoven, 2010), Hif-2a-mediated pex-
ophagy likely contributes to additional lipid alterations. More-
over, alterations in lipidmetabolismmay derive also from indirect
consequences of reduced peroxisome function like activation of
ER stress pathways and mitochondrial dysfunction (Baes and
Van Veldhoven, 2012; Faust and Kovacs, 2014).
Autophagy is an evolutionary conserved catabolic process
for degradation of macromolecules and organelles. Both nonse-
lective ‘‘bulk’’ autophagy and selective autophagy of specific
proteins or organelles have been described (Mizushima et al.,
2011; Schreiber and Peter, 2014). The key factor in selective
autophagy is specific cargo-recognizing receptors that connect
the cargo to the core autophagic machinery. Two pexophagy re-
ceptors, Atg30 and Atg36, have been identified in yeast (Farre´
et al., 2008; Motley et al., 2012), and their overexpression stimu-
lates pexophagy even under peroxisome-inducing conditions.
However, there are no orthologous genes in mammals, and no
pexophagy receptors have been identified. Previous studies
showed that hypoxia-induced macroautophagy or mitophagy
are Hif-1a dependent (Semenza, 2011), but a specific Hif-2a
function in the context of autophagy has not been reported.
While it remains an open question how Hif-2a induces pexoph-
agy at the detailed molecular level, several possibilities exist.
Hif-2a could induce the expression of a pexophagy receptor.
Overexpression of NBR1 and p62, which are receptors for selec-
tive autophagy of ubiquitinated targets, induces clustering and
degradation of peroxisomes in cell lines (Deosaran et al.,
2013), but Nbr1 and p62 are not induced by Hif-2a. Artificial
monoubiquitination of peroxisomal membrane proteins in
mammalian cells is sufficient to cause NBR1- and p62-depen-
dent pexophagy (Kim et al., 2008), but it is unknown if a peroxi-
somal membrane protein is ubiquitinated under pexophagy-
inducing conditions and whether subsequent interaction with
Nbr1 and/or p62 links ubiquitinated peroxisomes to the auto-
phagic machinery. One possibility is that Hif-2a induces an E3
ubiquitin ligase that mediates ubiquitination of a peroxisomal
membrane protein. However, Hif-2a did not induce the expres-
sion of peroxisomal E3 ligases (Pex2, Pex10, and Pex12). Alter-
natively, Nbr1 could be recruited to peroxisomes independently
of ubiquitin, because Nbr1 (but not p62) contains a membrane-
interacting domain capable of binding to peroxisomes (Deosaran
et al., 2013), and Nbr1 localized to peroxisomes even in control
livers. In addition, p62 is not required for pexophagy when
Nbr1 is in excess, but its binding to Nbr1 increases the efficiency
of Nbr1-mediated pexophagy (Deosaran et al., 2013). Since
3-MA treatment of Vhl/ mice induced significant clustering
of Nbr1- and p62-positive peroxisomes, we hypothesize that(C) Immunoblots of p62 and Nbr1 in liver lysates.
(D) Immunofluorescence of catalase, Nbr1, and p62 (shown in Figure S7F). The r
Arrowheads represent Nbr1-positive aggregates that colocalize with catalase. Arr
in the bottom panel show higher magnification of the colocalization of peroxisom
894 Cell Metabolism 22, 882–897, November 4, 2014 ª2014 ElsevierHif-2a signaling increases the rate of Nbr1 interaction with per-
oxisomes. The accumulation of Nbr1 on peroxisomes likely re-
cruits p62 to achieve a critical mass required for pexophagy.
This may concentrate sufficient ubiquitin-like modifiers (e.g.,
LC3 and Gabaraps) in close proximity to peroxisomes to prime
phagophore assembly. Hif-2a could also promote a posttran-
slational modification of a peroxisomal membrane protein or
Nbr1 that induces pexophagy. For example, hypoxia-induced
dephosphorylation of FUNDC1, a mitochondrial outer mem-
brane protein, enhances its interaction with the core autophagic
machinery and promotes mitophagy (Liu et al., 2012). Nbr1
phosphorylation by glycogen synthase kinase 3 prevents the ag-
gregation of ubiquitinated proteins and their selective autopha-
gic degradation (Nicot et al., 2014). Hif-2a could activate
mRNA translation of a pexophagy receptor or a protein-modi-
fying gene as part of its recently identified transcription-indepen-
dent role in the regulation of translation (Uniacke et al., 2012).
The identification of Hif-2a as a major inducer of pexophagy pro-
vides now a path toward delineating the underlying mechanism.
Low numbers of peroxisomes have been observed in various
tumor cells (Frederiks et al., 2010). Our analysis of more than
200 ccRCC tissue samples revealed a striking correlation be-
tween high HIF-2a levels and loss of peroxisomes, further sup-
porting a direct association between activation of HIF-2a and
pexophagy. Of particular interest in this regard is the relation-
ship between peroxisome abundance and the histological tu-
mor differentiation grade, since peroxisome abundance is
reduced more frequently in well-differentiated tumors. The ma-
jority of ccRCC is associated with constitutive upregulation of
HIF-a due to loss of pVHL function. HIF-2a is considered to
be a core oncogenic driver in ccRCC and is upregulated in
the vast majority of solid tumors (Franovic et al., 2009; Qing
and Simon, 2009). Accumulation of neutral lipids and glycogen
are characteristic features of ccRCCs. Thus, alterations in lipid
metabolism as a result of deregulated peroxisome homeostasis
play likely an important but unappreciated role in ccRCC devel-
opment (Currie et al., 2013; Santos and Schulze, 2012). Fatty
acids support cancer growth by providing substrates for energy
production or by generating building blocks for membranes and
signaling lipids in proliferating cells. VLC-PUFAs could be con-
verted to eicosanoids, biologically active lipids involved in
inflammation and carcinogenesis. Eicosanoids are degraded
in peroxisomes, and dysbalance of peroxisome homeostasis
will affect eicosanoid signaling. Peroxisomes are essential for
the synthesis of ether lipids, and they are increased in aggres-
sive cancers (Lodhi and Semenkovich, 2014). Changes in
VLCFAs, ether lipids, and DHA levels affect membrane proper-
ties, thereby influencing membrane microdomain organization
and trafficking pathways (Lodhi and Semenkovich, 2014; Obara
et al., 2013).
In summary, the findings presented here provide now an
impetus to further characterize the functional consequences of
HIF-2a-driven pexophagy and associated lipid alterations in
cancer and to exploit this knowledge for therapy.ight panel shows enlarged images of the boxed regions in the overlay panels.
ows represent peroxisome clusters in livers of 3-MA-treated Vhl/mice. Insets
e clusters with Nbr1 in livers of 3-MA-treated Vhl/ mice.
Inc.
Figure 7. Strong HIF-2a Staining Correlates with a Reduction of Peroxisome Abundance in ccRCCs
(A) Characterization of peroxisome distribution and abundance in healthy kidney. Sequential sections of a biopsy from a healthy kidney were stained with specific
markers for proximal tubules (p), glomeruli (g), distal tubules (d), collecting duct (c), and with catalase as marker for peroxisomes.
(B) Immunofluorescence staining of a RCC TMA for catalase. Representative examples of ccRCC biopsies with varying abundance of peroxisomes are shown.
(C) Immunohistochemical staining of a RCC TMA for HIF-2a. Shown are representative images of biopsies that were classified as HIF-2a negative, weak, and
strong and correspond to biopsies that were deemed to contain many, medium, and few peroxisomes, respectively.
(D) Correlation of peroxisome abundance with HIF-2a staining in ccRCC tumor biopsies in a TMA.
(legend continued on next page)
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Mice
Albumin-Cre (B6.Cg-Tg(Alb-cre)21Mgn/J), Vhlf/f (C;129S-Vhl < tm1Jae > /J),
Hif1af/f (B6.129-Hif1a < tm3Rsjo > /J), and Hif2af/f (B6.Epas1 < tm1Mcs > /J)
mice were purchased from the Jackson Laboratory. Atg7f/f mice (B6.Cg-
Atg7 < tm1Tchi >) were obtained from the RIKEN Bio Resource Center (Ibar-
aki). Liver-specific inactivation of Vhl, Hif1a, Hif2a, and Atg7 was achieved
by mating with Albumin-Cremice. Cre-negative littermates were used as con-
trols. WY (50 mg/kg body weight/day) or PBA (1 g/kg/day) was administered
by gavage. CQ (10 mg/kg/day) or 3-MA (2 mg/kg/day) was administered by
intraperitoneal injection. All protocols for animal use and experiments were
approved by the Veterinary Office of Zurich (Switzerland).
Lipid Measurements by Liquid Chromatography-Tandem Mass
Spectrometry
Lipids from livers were extracted with the MTBE method, and data acquisition
was performed as described previously (Fauland et al., 2011).
Adenovirus
Adenovirus expressing HIF-2a P405/531A was generated by using the Rapid
Adenovirus Production System (Viraquest). The HA-HIF-2a P405/531A cDNA
was excised from pcDNA3.0-HA-HIF2a P405A/P531A (Addgene). The virus
expresses GFP from an independent promoter in addition to HIF-2a P405/
531A. Virus expressing only GFP served as control.
Analysis of Autophagy by Microscopy
The GFP-LC3-expressing adenovirus was delivered to P21 Vhlf/f and Vhl/
mice by tail-vein injection. After 7 days, mice received CQ (10 mg/kg/day) by
intraperitoneal injection for 2 days. Livers were harvested and immunostained
on paraffin sections against GFP. Punctuated GFP-LC3 structures were quan-
tified using the particle analysis tool of Imaris software. Thirty to fifty single cells
were evaluated in three Vhlf/f and Vhl/ mice.
Quantitative RT-PCR and Biochemistry Measurements
Analyses were performed as described in Kovacs et al. (2012). Antibodies are
listed in Table S3.
Histology and Immunohistochemistry
Experiments were performed as described in Kovacs et al. (2012). Antibodies
are listed in Table S3. Images were taken with a Leica SP2-AOBS confocal
laser scanning microscope. Fluorescent dyes were imaged sequentially in
frame interlacemode to eliminate crosstalk between the channels. For 3D visu-
alization (movie generation, orthogonal slicer tool), Imaris software was used.
3D-SIM experiments were realized on a DeltaVision OMX V4 Blaze (GE
Healthcare). 3D-SIM data were acquired with a fixed z distance of 125 nm,
15 images per z stack (three different illumination angles at 60 interval and
five different phases/angle). The superresolution stack was reconstructed in
softWoRx 6.0 (GE Healthcare) with channel-specific measured optical transfer
functions. As comparison, wide-field images were acquired (same z range and
z distance for 3D-SIM dates) and deconvolved with softWoRx 6.0. Image
registration for the different acquired channels was performed in softWoRx
6.0 with alignment parameters obtained from a TetraSpeck bead preparate
(bead diameter 0.2 mm). Reconstructed and registered images were 3D
rendered in Imaris. From the fluorescence information, surfaces were created
(surface area detail level: 0.08 mm).
Renal Tumor TMA
The construction of a renal tumor TMA and the tumors included have been
described previously (Mertz et al., 2008). Sequential sections of a healthy kid-(E) Correlation of peroxisome abundance with histological differentiation grade in
(F) Model for Hif-2a-mediated decrease in peroxisome abundance. Hypoxia or los
whereas it does not affect basal peroxisome biogenesis. Consequently, the red
activity leads to significant changes in the lipid profile, such as accumulation of V
receptor that induces peroxisome proliferation. Hif-2a signaling represses this liga
peroxisome proliferation and consequential restoration of peroxisome homeosta
metabolic activity. P, peroxisome.
896 Cell Metabolism 22, 882–897, November 4, 2014 ª2014 Elsevierney were stained against catalase and marker proteins for proximal tubules
and glomeruli, distal tubules, and collecting ducts, according to the standard
protocol at the pathology of the University Hospital Zu¨rich.
Statistical Analyses
Data are expressed asmean ± SD. Statistical significancewas evaluated by an
unpaired Student’s t test.
SUPPLEMENTAL INFORMATION
Supplemental Information includes seven figures, three tables, four movies,
and Supplemental Experimental Procedures and can be found with this article
online at http://dx.doi.org/10.1016/j.cmet.2014.09.017.
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